CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis.

The authors performed a meta-analysis of 33 studies examining the association of type 1 diabetes mellitus with polymorphisms in the cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene, including the A49G (29 comparisons), C(-318)T (three comparisons), and (AT)n microsatellite (six comparisons) polymorphisms. The studies included 5,637 cases of type 1 diabetes and 6,759 controls (4,775 and 5,829, respectively, for analysis of the A49G polymorphism). The random-effects odds ratio for the *G (Ala) allele versus the *A (Thr) allele was 1.45 (95% confidence interval (CI): 1.28, 1.65), with significant between-study heterogeneity (p < 0.001). The effect size tended to be higher in type 1 diabetes cases with age of onset <20 years (odds ratio (OR) = 1.61), and there was a significant association between the presence of glutamic acid decarboxylase-65 autoantibodies and the *G allele among type 1 diabetes cases (OR = 1.49). Larger studies showed more conservative results (p = 0.011). After exclusion of studies with fewer than 150 subjects and studies with significant deviation from Hardy-Weinberg equilibrium in the controls, the summary odds ratio was 1.40 (95% CI: 1.28, 1.54). Available data showed no strong association for the 106-base-pair allele of the microsatellite polymorphism (OR = 0.99, 95% CI: 0.64, 1.55) or the *T allele of the C(-318)T polymorphism (OR = 0.92, 95% CI: 0.45, 1.89). This meta-analysis demonstrates that the CTLA-4*G genotype is associated with type 1 diabetes.

[1]  J. Tuomilehto,et al.  A review of the recent epidemiological data on the worldwide incidence of Type 1 (insulin-dependent) diabetes mellitus , 1993, Diabetologia.

[2]  Thomas A Trikalinos,et al.  'Racial' differences in genetic effects for complex diseases , 2004, Nature Genetics.

[3]  R. Uibo,et al.  Type 1 diabetes is insulin −2221 MspI and CTLA‐4 +49 A/G polymorphism dependent , 2004, European journal of clinical investigation.

[4]  S. Azar,et al.  Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. , 2004, Human immunology.

[5]  S. Pearce,et al.  The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. , 2004, European journal of endocrinology.

[6]  E. Gale.  European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes , 2004, The Lancet.

[7]  J. Ilonen,et al.  A linkage study of 12 IDDM susceptibility loci in the Finnish population , 2004, Diabetes/metabolism research and reviews.

[8]  A. Ide,et al.  Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. , 2004, Journal of autoimmunity.

[9]  M. Knip,et al.  Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland , 1993, Diabetologia.

[10]  J. Ilonen,et al.  A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[11]  Muin J Khoury,et al.  The human genome project is complete. How do we develop a handle for the pump? , 2003, American journal of epidemiology.

[12]  John P A Ioannidis,et al.  Genetic associations: false or true? , 2003, Trends in molecular medicine.

[13]  A. Pérez-Lezaun,et al.  Association of the CTLA4 promoter region (−1661G allele) with type 1 diabetes in the South Moroccan population , 2003, Genes and Immunity.

[14]  S. Amemiya,et al.  Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. , 2003, Diabetes care.

[15]  Thomas A Trikalinos,et al.  Genetic associations in large versus small studies: an empirical assessment , 2003, The Lancet.

[16]  幸喜 毅.  CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease , 2003 .

[17]  M. Pani,et al.  A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes. , 2002, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[18]  Xulei Tang,et al.  CTLA-4 gene A/G polymorphism associated with diabetes mellitus in Han Chinese. , 2002, Chinese medical journal.

[19]  W. Klitz,et al.  Association of CTLA-4 variation with type I diabetes in Filipinos , 2002, Immunogenetics.

[20]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[21]  K. Ihara,et al.  Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes , 2002, Immunogenetics.

[22]  I. Fajardy,et al.  CTLA-4 49 A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect. , 2002, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[23]  P. Dřevínek,et al.  The CTLA4 +49 A/G dimorphism is not associated with type 1 diabetes in Czech children. , 2002, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[24]  R. Leslie,et al.  Impact of genetic and non-genetic factors in type 1 diabetes. , 2002, American journal of medical genetics.

[25]  A. Falorni,et al.  CTLA‐4 Gene Polymorphism Contributes to the Genetic Risk for Latent Autoimmune Diabetes in Adults , 2002, Annals of the New York Academy of Sciences.

[26]  P. Rieckmann,et al.  A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation , 2002, Immunogenetics.

[27]  T. Yanagawa,et al.  Relation of three polymorphisms of the CTLA-4 gene in patients with Graves’ disease , 2002, Journal of endocrinological investigation.

[28]  S. Pearce,et al.  An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. , 2002, Rheumatology.

[29]  M. Pinget,et al.  Markers for Risk of Type 1 Diabetes in Relatives of Alsacian Patients With Type 1 Diabetes , 2002, International journal of experimental diabetes research.

[30]  S. Sugihara,et al.  Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to Type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies , 2001, Clinical endocrinology.

[31]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[32]  D. Osei-Hyiaman,et al.  Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese. , 2001, Diabetes.

[33]  Nobuo Matsuura,et al.  Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population , 2001, Immunogenetics.

[34]  A. Maxwell,et al.  Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population , 2001, Genes and Immunity.

[35]  T. Maruyama,et al.  No Association of Type 1 Diabetes with a Microsatellite Marker for CTLA-4 in a Japanese Population , 2001, Autoimmunity.

[36]  高良 正樹.  Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease , 2001 .

[37]  N. Smaoui,et al.  Étude de l'association entre diabète type 1 et polymorphisme du gène CTLA-4 dans une population tunisienne , 2001 .

[38]  S. Hmida,et al.  [Association between type 1 diabetes and polymorphism of the CTLA-4 gene in a Tunisian population]. , 2001, Pathologie-biologie.

[39]  Y. J. Lee,et al.  The Promoter Region of the CTLA4 Gene is Associated with Type 1 Diabetes Mellitus , 2001, Journal of pediatric endocrinology & metabolism : JPEM.

[40]  M. Fisfalen,et al.  CTLA-4 Gene Polymorphism at Position 49 in Exon 1 Reduces the Inhibitory Function of CTLA-4 and Contributes to the Pathogenesis of Graves’ Disease1 , 2000, The Journal of Immunology.

[41]  J. Ilonen,et al.  Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. , 2000, Diabetes.

[42]  N. Takasu,et al.  Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. , 2000, Diabetes care.

[43]  S. Pearce,et al.  CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. , 2000, Journal of hepatology.

[44]  J. Rotter,et al.  Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. , 2000, Diabetes.

[45]  F. Huang,et al.  Association of CTLA4 gene A–G polymorphism with type 1 diabetes in Chinese children , 2000, Clinical endocrinology.

[46]  F. Pociot,et al.  CTLA-4 in autoimmune diseases – a general susceptibility gene to autoimmunity? , 2000, Genes and Immunity.

[47]  Å. Lernmark,et al.  The Length of the CTLA-4 Microsatellite (AT)N-Repeat Affects the Risk for Type 1 Diabetes: For the Swedish Childhood Diabetes Study Group , 2000, Autoimmunity.

[48]  C. Bunker,et al.  HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. , 2000, Epidemiologic reviews.

[49]  S. Ishikawa,et al.  Association of CTLA‐4 polymorphism with positive anti‐GAD antibody in Japanese subjects with type 1 diabetes mellitus , 1999, Clinical endocrinology.

[50]  K. Eguchi,et al.  CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. , 1999, Diabetes research and clinical practice.

[51]  J. Ioannidis,et al.  Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. , 1999, Journal of clinical epidemiology.

[52]  A. de Leiva,et al.  IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent). , 1999, Autoimmunity.

[53]  T. Saruta,et al.  Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects. , 1999, Autoimmunity.

[54]  H. Harbo,et al.  CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. , 1999, Tissue antigens.

[55]  J. Bach,et al.  CTLA-4 gene polymorphism is associated with predisposition to coeliac disease , 1998, Gut.

[56]  K. Usadel,et al.  CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families. , 1998, Diabetes.

[57]  N. Risch,et al.  A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus , 1998, Nature Genetics.

[58]  J. Ilonen,et al.  Screening for genetic IDDM risk and prevention trials in infancy. , 1998, Diabetes/metabolism reviews.

[59]  S. Caillat-Zucman,et al.  CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland. , 1998, Diabetes & metabolism.

[60]  I. Fajardy,et al.  Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients. , 1998, Clinical and diagnostic virology.

[61]  M. V. von Herrath,et al.  Role of viruses in type I diabetes. , 1998, Seminars in immunology.

[62]  J. Ioannidis.  Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. , 1998, JAMA.

[63]  N. Kuzuya,et al.  Association of CTLA-4 Gene A-G Polymorphism (IDDM12 Locus) With Acute-Onset and Insulin-Depleted IDDM as Well as Autoimmune Thyroid Disease (Graves' Disease and Hashimoto's Thyroiditis) in the Japanese Population , 1998, Diabetes.

[64]  C. Boitard,et al.  No Major Role for the CTLA-4 Gene in the Association of Autoimmune Thyroid Disease With IDDM , 1998, Diabetes.

[65]  K. Usadel,et al.  CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. , 1998, Tissue antigens.

[66]  J. Tuomilehto,et al.  Sex difference in the incidence of insulin-dependent diabetes mellitus: an analysis of the recent epidemiological data. World Health Organization DIAMOND Project Group. , 1997, Diabetes/metabolism reviews.

[67]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[68]  F. Schuit,et al.  CTLA‐4 gene polymorphism confers susceptibility to insulin‐dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers , 1997, Clinical and experimental immunology.

[69]  M. Tsai,et al.  Analysis of Candidate Genes for Susceptibility to Type I Diabetes: A Case-Control and Family-Association Study of Genes on Chromosome 2q31–35 , 1997, Diabetes.

[70]  M. Rewers,et al.  The Role of Enteroviral Infections in the Development of IDDM: Limitations of Current Approaches , 1997, Diabetes.

[71]  K. Usadel,et al.  CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.

[72]  J. Todd,et al.  Panning for gold: genome-wide scanning for linkage in type 1 diabetes. , 1996, Human molecular genetics.

[73]  K. Deichmann,et al.  An Mse I RFLP in the human CTLA4 promotor. , 1996, Biochemical and biophysical research communications.

[74]  J. Todd,et al.  The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. , 1996, Human molecular genetics.

[75]  A. Foulis.  The pathology of the endocrine pancreas in type 1 (insulin‐dependent) diabetes mellitus , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[76]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[77]  J. Bluestone,et al.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.

[78]  J. Todd,et al.  Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus , 1995, Nature Genetics.

[79]  A. Green,et al.  Variation by age group and seasonality at diagnosis of childhood IDDM in Europe. The EURODIAB ACE Study Group. , 1995, Diabetologia.

[80]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[81]  J. Todd,et al.  A genome-wide search for human type 1 diabetes susceptibility genes , 1994, Nature.

[82]  M. Menser,et al.  A fifty-year follow-up of congenital rubella , 1992, The Lancet.

[83]  M. Mattei,et al.  CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. , 1991, Journal of immunology.

[84]  P. Easterbrook,et al.  Publication bias in clinical research , 1991, The Lancet.

[85]  W. Klitz,et al.  HLA and insulin gene associations with IDDM , 1989, Genetic epidemiology.

[86]  M. Lefranc,et al.  Human Ig superfamily CTLA‐4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA‐4 cytoplasmic domains , 1988, European journal of immunology.

[87]  J. Todd,et al.  A molecular basis for MHC class II--associated autoimmunity. , 1988, Science.

[88]  J. Todd,et al.  HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.

[89]  F. Denizot,et al.  A new member of the immunoglobulin superfamily—CTLA-4 , 1987, Nature.

[90]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[91]  J. Karam,et al.  A Polymorphic Locus Near the Human Insulin Gene Is Associated with Insulin-dependent Diabetes Melliitus , 1984, Diabetes.